Stay updated on Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial
Sign up to get notified when there's something new on the Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial page.

Latest updates to the Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0. The study record content remains unchanged.SummaryDifference0.1%

- Check17 days agoChange DetectedAn NIH-wide banner announces a website transition and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference0.7%

- Check24 days agoChange DetectedThe website footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check31 days agoChange DetectedThe footer's site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check45 days agoChange DetectedThere are no listed additions or deletions to interpret. As a result, no update can be inferred from the change data.SummaryDifference0.1%

- Check52 days agoChange DetectedThe Record History page adds a new latest revision tag: Revision: v3.7.0, replacing the previous Revision: v3.6.6.SummaryDifference0.1%

Stay in the know with updates to Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial page.